Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q1I8
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 9 |
GO:0006259 | DNA metabolic process | 4 | 9 |
GO:0006281 | DNA repair | 5 | 9 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 9 |
GO:0006807 | nitrogen compound metabolic process | 2 | 9 |
GO:0006950 | response to stress | 2 | 9 |
GO:0006974 | DNA damage response | 4 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0009987 | cellular process | 1 | 9 |
GO:0033554 | cellular response to stress | 3 | 9 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 9 |
GO:0043170 | macromolecule metabolic process | 3 | 9 |
GO:0044237 | cellular metabolic process | 2 | 9 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 9 |
GO:0046483 | heterocycle metabolic process | 3 | 9 |
GO:0050896 | response to stimulus | 1 | 9 |
GO:0051716 | cellular response to stimulus | 2 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:0090304 | nucleic acid metabolic process | 4 | 9 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003727 | single-stranded RNA binding | 5 | 2 |
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004518 | nuclease activity | 4 | 9 |
GO:0004519 | endonuclease activity | 5 | 9 |
GO:0004521 | RNA endonuclease activity | 5 | 2 |
GO:0004540 | RNA nuclease activity | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 9 |
GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 6 | 2 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 2 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.483 |
CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.336 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.616 |
CLV_PCSK_KEX2_1 | 257 | 259 | PF00082 | 0.340 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.555 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.632 |
CLV_PCSK_SKI1_1 | 278 | 282 | PF00082 | 0.336 |
CLV_PCSK_SKI1_1 | 380 | 384 | PF00082 | 0.355 |
DEG_SPOP_SBC_1 | 301 | 305 | PF00917 | 0.555 |
DEG_SPOP_SBC_1 | 386 | 390 | PF00917 | 0.703 |
DOC_CYCLIN_RxL_1 | 307 | 318 | PF00134 | 0.510 |
DOC_PP2B_LxvP_1 | 131 | 134 | PF13499 | 0.390 |
DOC_PP2B_LxvP_1 | 269 | 272 | PF13499 | 0.471 |
DOC_PP2B_LxvP_1 | 29 | 32 | PF13499 | 0.425 |
DOC_PP2B_LxvP_1 | 82 | 85 | PF13499 | 0.532 |
DOC_PP4_FxxP_1 | 101 | 104 | PF00568 | 0.374 |
DOC_PP4_FxxP_1 | 137 | 140 | PF00568 | 0.375 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.432 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 301 | 305 | PF00917 | 0.555 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 382 | 386 | PF00917 | 0.672 |
DOC_USP7_MATH_1 | 387 | 391 | PF00917 | 0.740 |
DOC_WW_Pin1_4 | 136 | 141 | PF00397 | 0.470 |
DOC_WW_Pin1_4 | 302 | 307 | PF00397 | 0.510 |
DOC_WW_Pin1_4 | 316 | 321 | PF00397 | 0.388 |
DOC_WW_Pin1_4 | 339 | 344 | PF00397 | 0.535 |
LIG_14-3-3_CanoR_1 | 154 | 161 | PF00244 | 0.386 |
LIG_14-3-3_CanoR_1 | 205 | 209 | PF00244 | 0.536 |
LIG_APCC_ABBA_1 | 222 | 227 | PF00400 | 0.419 |
LIG_BIR_III_4 | 18 | 22 | PF00653 | 0.486 |
LIG_Clathr_ClatBox_1 | 245 | 249 | PF01394 | 0.455 |
LIG_deltaCOP1_diTrp_1 | 142 | 150 | PF00928 | 0.415 |
LIG_FHA_1 | 128 | 134 | PF00498 | 0.516 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.346 |
LIG_FHA_1 | 351 | 357 | PF00498 | 0.488 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.542 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.536 |
LIG_FHA_2 | 295 | 301 | PF00498 | 0.496 |
LIG_GBD_Chelix_1 | 261 | 269 | PF00786 | 0.296 |
LIG_GBD_Chelix_1 | 351 | 359 | PF00786 | 0.336 |
LIG_LIR_Apic_2 | 135 | 140 | PF02991 | 0.398 |
LIG_LIR_Gen_1 | 138 | 148 | PF02991 | 0.414 |
LIG_LIR_Gen_1 | 214 | 224 | PF02991 | 0.536 |
LIG_LIR_Gen_1 | 227 | 237 | PF02991 | 0.536 |
LIG_LIR_LC3C_4 | 353 | 357 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 138 | 144 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 214 | 219 | PF02991 | 0.536 |
LIG_LIR_Nem_3 | 227 | 232 | PF02991 | 0.477 |
LIG_LIR_Nem_3 | 321 | 327 | PF02991 | 0.496 |
LIG_LYPXL_yS_3 | 193 | 196 | PF13949 | 0.471 |
LIG_MYND_1 | 309 | 313 | PF01753 | 0.510 |
LIG_Pex14_2 | 137 | 141 | PF04695 | 0.366 |
LIG_Pex14_2 | 225 | 229 | PF04695 | 0.419 |
LIG_SH2_CRK | 324 | 328 | PF00017 | 0.487 |
LIG_SH2_PTP2 | 340 | 343 | PF00017 | 0.555 |
LIG_SH2_STAT5 | 326 | 329 | PF00017 | 0.507 |
LIG_SH2_STAT5 | 340 | 343 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 378 | 381 | PF00017 | 0.607 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.477 |
LIG_SH3_3 | 157 | 163 | PF00018 | 0.337 |
LIG_SH3_3 | 250 | 256 | PF00018 | 0.489 |
LIG_SH3_3 | 303 | 309 | PF00018 | 0.508 |
LIG_SH3_4 | 4 | 11 | PF00018 | 0.523 |
LIG_Sin3_3 | 352 | 359 | PF02671 | 0.496 |
LIG_SUMO_SIM_anti_2 | 166 | 171 | PF11976 | 0.487 |
LIG_SUMO_SIM_par_1 | 244 | 249 | PF11976 | 0.471 |
LIG_TRAF2_1 | 40 | 43 | PF00917 | 0.479 |
LIG_WRC_WIRS_1 | 216 | 221 | PF05994 | 0.464 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.503 |
MOD_CK1_1 | 304 | 310 | PF00069 | 0.511 |
MOD_CK1_1 | 318 | 324 | PF00069 | 0.397 |
MOD_CK1_1 | 385 | 391 | PF00069 | 0.657 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.393 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.464 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.536 |
MOD_CK2_1 | 215 | 221 | PF00069 | 0.526 |
MOD_CK2_1 | 294 | 300 | PF00069 | 0.538 |
MOD_GlcNHglycan | 120 | 124 | PF01048 | 0.685 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.461 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.316 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.708 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.654 |
MOD_GlcNHglycan | 384 | 387 | PF01048 | 0.455 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.540 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.471 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.536 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.550 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.420 |
MOD_GSK3_1 | 381 | 388 | PF00069 | 0.584 |
MOD_N-GLC_1 | 76 | 81 | PF02516 | 0.644 |
MOD_NEK2_1 | 106 | 111 | PF00069 | 0.454 |
MOD_NEK2_1 | 228 | 233 | PF00069 | 0.556 |
MOD_NEK2_1 | 236 | 241 | PF00069 | 0.516 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.555 |
MOD_NEK2_1 | 355 | 360 | PF00069 | 0.471 |
MOD_NEK2_2 | 215 | 220 | PF00069 | 0.464 |
MOD_PIKK_1 | 236 | 242 | PF00454 | 0.555 |
MOD_PIKK_1 | 318 | 324 | PF00454 | 0.555 |
MOD_PKA_2 | 153 | 159 | PF00069 | 0.329 |
MOD_PKA_2 | 204 | 210 | PF00069 | 0.536 |
MOD_Plk_1 | 106 | 112 | PF00069 | 0.456 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.427 |
MOD_Plk_1 | 173 | 179 | PF00069 | 0.471 |
MOD_Plk_1 | 76 | 82 | PF00069 | 0.425 |
MOD_Plk_4 | 106 | 112 | PF00069 | 0.413 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.562 |
MOD_Plk_4 | 355 | 361 | PF00069 | 0.510 |
MOD_ProDKin_1 | 136 | 142 | PF00069 | 0.466 |
MOD_ProDKin_1 | 302 | 308 | PF00069 | 0.510 |
MOD_ProDKin_1 | 316 | 322 | PF00069 | 0.388 |
MOD_ProDKin_1 | 339 | 345 | PF00069 | 0.535 |
TRG_DiLeu_BaLyEn_6 | 307 | 312 | PF01217 | 0.592 |
TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.471 |
TRG_ENDOCYTIC_2 | 324 | 327 | PF00928 | 0.496 |
TRG_ER_diArg_1 | 256 | 258 | PF00400 | 0.536 |
TRG_ER_diArg_1 | 360 | 363 | PF00400 | 0.605 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILN9 | Leptomonas seymouri | 53% | 100% |
A0A1X0P8I3 | Trypanosomatidae | 43% | 100% |
A0A3S7XAV3 | Leishmania donovani | 91% | 100% |
A0A422NIX5 | Trypanosoma rangeli | 45% | 100% |
A4HPA1 | Leishmania braziliensis | 71% | 100% |
A4IDK7 | Leishmania infantum | 91% | 100% |
E9AT10 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 99% |